STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo targets tough cancers in early trial
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head/neck cancer that had spread or returned. The goal was to see if the combo could shrink tumors better than standard treatments. Participants had …
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of the immune-boosting drug durvalumab and a precise, high-dose radiation treatment called SBRT for people with stage III lung cancer. The goal was to see if adding SBRT after standard chemoradiation could improve disease control and be safe. Only …
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 04, 2026 16:21 UTC